|
Article Excerpt
Company Plans to Expand in Opportune Market
MINNEAPOLIS -- AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ:AGAM) has received regulatory approvals and licenses in China for its AMPLATZER([R]) PFO Occluder and AMPLATZER([R]) Multi-Fenestrated Septal Occluder "Cribriform." The company has also received regulatory approval for its AMPLATZER([R]) Vascular Plug II in China, and its license is pending. The company plans to make the products available through its distributor Abbott Vascular, a division of Abbott Laboratories, Inc.
"We see considerable opportunities in developing markets, such as China, and we are excited to expand our presence there," said John Barr, president and chief executive officer of AGA Medical. "Today's announcement demonstrates our ability to obtain product approvals in important markets, and we look forward to making AMPLATZER products more widely available."
About the...
|
|
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
